Absorbable Sutures

Global Absorbable Sutures Market to Reach US$3.3 Billion by 2030

The global market for Absorbable Sutures estimated at US$2.8 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Monofilament Sutures, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Braided Sutures segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$773.2 Million While China is Forecast to Grow at 5.0% CAGR

The Absorbable Sutures market in the U.S. is estimated at US$773.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$639.0 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Absorbable Sutures Market – Key Trends & Drivers Summarized

Why Are Absorbable Sutures Gaining Preference in Surgical Wound Closure, Tissue Healing, and Post-Operative Care?
Absorbable sutures are increasingly favored in modern surgical practices due to their ability to naturally degrade within the body, eliminating the need for suture removal and reducing patient follow-up visits. These sutures are designed to maintain tensile strength for a defined period, then gradually hydrolyze or enzymatically break down, depending on the material composition. Their use spans across general surgery, gynecology, urology, orthopedics, dental procedures, and dermatological interventions where internal tissue approximation is required without permanent foreign material retention.

The shift toward minimally invasive procedures and enhanced recovery protocols is accelerating demand for absorbable sutures, as they contribute to reduced scarring, lower infection risk, and greater patient comfort. Surgeons prefer them in deep tissue closures and layered suturing where long-term support is not necessary. The growing volume of surgical interventions—driven by aging populations, trauma cases, chronic disease management, and elective procedures—is further reinforcing the utility of absorbable sutures as a standard of care in wound management.

Clinical guidelines increasingly recommend absorbable options in pediatric surgeries, obstetric applications (e.g., C-sections, episiotomies), and gastrointestinal procedures, where suture removal would otherwise pose logistical or physiological challenges. Their broad compatibility with tissue types and anatomical sites, coupled with regulatory approval for use across a wide spectrum of specialties, positions absorbable sutures as a practical and patient-friendly alternative to non-absorbable materials.

How Are Material Innovation, Antibacterial Enhancement, and Knotless Technologies Advancing Absorbable Suture Performance?
Advancements in suture materials are central to improving the functional reliability and clinical outcomes of absorbable sutures. Traditional materials like polyglycolic acid (PGA), polylactic acid (PLA), and polydioxanone (PDO) continue to be refined for better tensile retention, absorption timelines, and biocompatibility. Newer copolymer blends and glycolide-caprolactone formulations offer improved pliability and knot security, catering to surgeon preferences across different procedural settings.

Antibacterial absorbable sutures, often coated with triclosan or other antimicrobial agents, are gaining traction in high-risk surgical environments to reduce the incidence of surgical site infections (SSIs). These coatings help inhibit bacterial colonization on the suture surface during the early post-operative period, aligning with global hospital efforts to improve infection control and meet clinical safety standards. As antimicrobial resistance remains a critical concern, such innovations provide an added layer of prophylactic protection in vulnerable patients.

Barbed and knotless absorbable sutures represent another leap forward, streamlining tissue closure by distributing tension more evenly and eliminating the need for traditional knots. This not only reduces procedure time but also minimizes tissue trauma and foreign body reaction. These sutures are particularly useful in laparoscopic and robotic-assisted surgeries, where access and maneuverability are constrained. As precision and workflow efficiency become surgical priorities, such suture technologies are gaining widespread adoption in both hospital and ambulatory surgical center settings.

Which Surgical Specialties, Healthcare Providers, and Global Markets Are Driving Absorbable Suture Demand?
The adoption of absorbable sutures is strongest in general surgery, gynecology, orthopedics, cardiovascular surgery, and dental care. These specialties routinely require layered closures, internal ligatures, and subcutaneous suturing techniques where biodegradability adds clinical and operational value. In gynecological and obstetric procedures, absorbable sutures are used extensively for uterine repair, perineal closure, and laparoscopic incisions. Orthopedic surgeons apply them for soft tissue approximation in ligament and tendon repair, especially in sports medicine and trauma cases.

Hospitals and large surgical centers remain the primary purchasers, given their high procedural volumes and broad specialty coverage. However, outpatient clinics, ambulatory surgical centers (ASCs), and dental practices are increasingly adopting absorbable sutures as they expand into more complex procedures previously confined to inpatient settings. The convenience, cost-efficiency, and post-operative benefits of absorbable sutures are well-aligned with the business models of these high-turnover, short-stay facilities.

Regionally, North America and Europe lead in both consumption and innovation, supported by robust healthcare infrastructure, high surgical rates, and favorable reimbursement systems. Asia-Pacific is witnessing strong growth, driven by rising healthcare investments, expanding surgical access, and local manufacturing initiatives. Emerging markets in Latin America, the Middle East, and Africa are adopting absorbable sutures as part of broader medical modernization efforts, particularly in maternal health, trauma care, and general surgery programs supported by public health systems and NGOs.

What Strategic Forces Are Shaping the Future Role of Absorbable Sutures in Surgical Innovation and Global Health Delivery?
The strategic relevance of absorbable sutures is rising as surgical best practices evolve toward minimally invasive, patient-centric, and value-based models of care. Their ability to enhance healing, reduce complications, and streamline post-operative management aligns with health system goals to improve outcomes while lowering resource utilization. As global surgery volumes increase and outpatient procedures become more complex, the demand for versatile, low-maintenance closure materials is poised to grow.

Customization of suture properties—such as absorption rate, tensile strength, and antimicrobial protection—is allowing manufacturers to create procedure-specific solutions that improve surgical precision and recovery timelines. Integration with digital surgery platforms, robotic arms, and suture-assist devices is further expanding their application across high-tech operating environments. Meanwhile, sustainability initiatives are encouraging innovation in bio-based materials and eco-friendly packaging to reduce medical waste.

As surgical access expands in developing regions and post-operative protocols prioritize patient convenience and recovery efficiency, absorbable sutures are becoming a cornerstone of modern wound closure strategies. Could their evolution into smarter, multifunctional biomaterials redefine the future of surgical healing across global healthcare systems?

SCOPE OF STUDY:

The report analyzes the Absorbable Sutures market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Monofilament Sutures, Braided Sutures); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• AD Surgical
• Advanced Medical Solutions Group plc
• Assut Medical Sàrl
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Clinisut
• ConMed Corporation
• CP Medical, Inc.
• DemeTECH Corporation
• Ethicon, Inc. (Johnson & Johnson)
• Integra LifeSciences Corporation
• Internacional Farmacéutica S.A. de C.V.
• Lotus Surgicals Pvt. Ltd.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• Péters Surgical
• Smith & Nephew plc
• Sutures India Pvt. Ltd. (Healthium Medtech)
• Surgical Specialties Corporation
• Teleflex Incorporated

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.